Market Data Forecast

Know the Drug Side Effects Beforehand with Companion Diagnostics, Europe Markets.

The Europe Companion Diagnostics Market was worth USD 606.1 million in 2016 and estimated to be growing at a CAGR of 20.66%, to reach USD 1,802.3 million by 2022.

 

Hyderabad, India -- (SBWIRE) -- 03/13/2018 -- A Companion Diagnostic is a therapeutic gadget, frequently an in vitro gadget, which gives data that is basic to understand the method to safely use the drug. The test enables the doctor to make sure that the drugs would not cause side effects that outdo the benefit it causes.

View Sample Report: https://www.marketdataforecast.com/market-reports/europe-companion-diagnostics-market-642/request-sample

The Europe companion diagnostics market was estimated to be at a market value of USD 606 Million in 2016 and is projected to rise at a CAGR 20.66% to reach USD 1,802 Billion by 2021.

The key components driving the development of Companion Diagnostics market incorporate the expanded lung malignancy cases, developing number of hereditary testing, rising requirement for customized pharmaceuticals, and administrative rules that help the market. The disclosure of biomarkers and co-improvement of medication and relating diagnostics are also expected to have a positive impact on the market expansion.

Read the full report: https://www.marketdataforecast.com/market-reports/europe-companion-diagnostics-market-642/

However, high costs and difficulty in developing companion diagnostics for hereditary conditions and ailments related nervous system are expected to restrict the market growth. Supporting the inducements of all the stakeholders is also a major challenge for the market expansion.
Geographically, the market is categorized into UK, Spain, Germany, France and others. Europe occupies the second largest market share after North America owing to the immense scope of research in this field.

Some of the key players of Europe companion diagnostics market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc., Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.

Customize report: https://www.marketdataforecast.com/market-reports/europe-companion-diagnostics-market-642/customize-report

About MarketDataForecast™-
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.

Related reports:
Europe Genetic Testing Market - https://www.marketdataforecast.com/market-reports/europe-genetic-testing-market-38/
Europe Head and Neck Cancer Diagnostics Market – https://www.marketdataforecast.com/market-reports/europe-head-and-neck-cancer-diagnostics-market-52/

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626